TABLE 27.
Distribution of reported cases of human salmonellosis acquired in the EU, 2020–2022, for the six most frequently reported serovars in 2022.
| Serovar | 2022 | 2021 | 2020 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Cases | MSs | % | Cases | MSs | % | Cases | MSs | % | |
| Enteritidis | 19,079 | 24 | 67.3 | 23,928 | 24 | 69.6 | 21,203 | 23 | 68.7 |
| Typhimurium | 3712 | 23 | 13.1 | 4076 | 24 | 11.9 | 3702 | 22 | 12.0 |
| Monophasic Typhimurium 1,4,[5],12:i:‐ | 1217 | 14 | 4.3 | 1519 | 15 | 4.4 | 1530 | 16 | 5.0 |
| Infantis | 649 | 22 | 2.3 | 667 | 24 | 1.9 | 716 | 21 | 2.3 |
| Derby | 252 | 17 | 0.89 | 249 | 17 | 0.72 | 260 | 17 | 0.84 |
| Coeln | 199 | 16 | 0.70 | 331 | 15 | 0.96 | 201 | 17 | 0.65 |
| Other | 3230 | – | 11.4 | 3607 | – | 10.5 | 3234 | – | 10.5 |
| Total a | 28,338 | 24 | 100.0 | 34,377 | 24 | 100.0 | 30,846 | 23 | 100.0 |
Abbreviations: MSs, Member States; –, Data not reported.
a
Only isolates with the complete antigenic formula and/or serovar name have been considered.